CVS Health Co. (NYSE:CVS) Shares Purchased by Donaldson Capital Management LLC

Donaldson Capital Management LLC boosted its stake in CVS Health Co. (NYSE:CVS) by 9.2% in the 4th quarter, Holdings Channel reports. The firm owned 9,677 shares of the pharmacy operator’s stock after purchasing an additional 812 shares during the period. Donaldson Capital Management LLC’s holdings in CVS Health were worth $764,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in CVS. Weik Capital Management grew its stake in shares of CVS Health by 0.7% in the first quarter. Weik Capital Management now owns 17,600 shares of the pharmacy operator’s stock worth $1,781,000 after acquiring an additional 120 shares in the last quarter. FCA Corp TX grew its stake in shares of CVS Health by 0.6% in the first quarter. FCA Corp TX now owns 20,109 shares of the pharmacy operator’s stock worth $2,035,000 after acquiring an additional 122 shares in the last quarter. Arvest Trust Co. N A grew its stake in shares of CVS Health by 1.2% in the fourth quarter. Arvest Trust Co. N A now owns 11,157 shares of the pharmacy operator’s stock worth $1,040,000 after acquiring an additional 131 shares in the last quarter. SOA Wealth Advisors LLC. grew its stake in shares of CVS Health by 4.9% in the fourth quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock worth $226,000 after acquiring an additional 133 shares in the last quarter. Finally, Apella Capital LLC grew its stake in shares of CVS Health by 4.2% in the fourth quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock worth $272,000 after acquiring an additional 136 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. StockNews.com cut shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Royal Bank of Canada decreased their price objective on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research report on Thursday, February 8th. Barclays assumed coverage on shares of CVS Health in a research report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective for the company. SVB Leerink assumed coverage on shares of CVS Health in a research report on Monday, February 26th. They set an “outperform” rating and a $88.00 price objective for the company. Finally, Wells Fargo & Company decreased their price objective on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating for the company in a research report on Monday, April 8th. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $89.44.

Insider Activity

In related news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the transaction, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.24% of the company’s stock.

CVS Health Stock Performance

Shares of NYSE:CVS traded up $1.01 on Tuesday, reaching $69.97. The company’s stock had a trading volume of 2,479,037 shares, compared to its average volume of 10,838,397. The stock’s 50-day moving average is $75.78 and its two-hundred day moving average is $73.78. CVS Health Co. has a 52-week low of $64.41 and a 52-week high of $83.25. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The stock has a market capitalization of $88.20 billion, a P/E ratio of 10.86, a PEG ratio of 0.91 and a beta of 0.52.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The business had revenue of $93.81 billion during the quarter, compared to analysts’ expectations of $90.58 billion. During the same period in the prior year, the company earned $1.99 earnings per share. The business’s revenue was up 11.9% compared to the same quarter last year. As a group, sell-side analysts forecast that CVS Health Co. will post 8.33 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.80%. CVS Health’s payout ratio is 41.18%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.